Leela Barham
Leela Barham
Latest posts from :
The first product has now gone completely through EAMS: what lessons can other...
Doubling of Scottish New Medicines Fund: Good or Bad?
But just when is access really early, and what are the options for companies to...
Speed of access matters
Leela Barham reports on how the pharma industry can make the most of working...
Leela Barham looks at how bringing together launch and market access plans can...
Leela Barham explores how different HTA approaches could affect market access...
Leela Barham explores the potential effect of value-based pricing on...
Leela Barham looks at the proposed reforms of the NHS in England and what they...
Leela Barham looks at the proposed reforms of the NHS in England and what they...